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The RNA modification N6-methyladenosine (m6A)
post-transcriptionally regulates RNA function. The
cellularmachinery that controlsm6A includesmethyl-
transferases and demethylases that add or remove
this modification, as well as m6A-binding YTHDF pro-
teins that promote the translation or degradation of
m6A-modifiedmRNA.Wedemonstrate thatm6Amod-
ulates infection by hepatitis C virus (HCV). Depletion
of m6A methyltransferases or an m6A demethylase,
respectively, increases or decreases infectious HCV
particle production. During HCV infection, YTHDF
proteins relocalize to lipid droplets, sites of viral as-
sembly, and their depletion increases infectious viral
particles. We further mapped m6A sites across the
HCV genome and determined that inactivating m6A
inoneviral genomic region increasesviral titerwithout
affecting RNA replication. Additional mapping of m6A
on the RNA genomes of other Flaviviridae, including
dengue, Zika, yellow fever, and West Nile virus, iden-
tifies conserved regionsmodified bym6A. Altogether,
this work identifies m6A as a conserved regulatory
mark across Flaviviridae genomes.
INTRODUCTION
The chemical modification of RNA is an important post-tran-
scriptional regulator of RNA. Of the many known RNA modifica-654 Cell Host & Microbe 20, 654–665, November 9, 2016 ª 2016 The
This is an open access article under the CC BY license (http://creativetions, N6-methyladenosine (m6A) is the most abundant internal
modification of eukaryotic mRNAs, contributing to RNA struc-
ture, localization, and function (Fu et al., 2014; Meyer and Jaf-
frey, 2014). m6A regulates many biological processes, including
stress responses, fertility, stem cell differentiation, circadian
rhythms, microRNA (miRNA) biogenesis, and cancer (Li and
Mason, 2014; Saletore et al., 2012; Yue et al., 2015; Zhou
et al., 2015). However, little is known about its effects on micro-
bial infection. m6A has long been known to be present in the
RNA transcripts of viruses with nuclear replication, such as influ-
enza A virus, simian virus 40, Rous sarcoma virus, avian sar-
coma virus, and adenovirus (Dimock and Stoltzfus, 1977;
Kane and Beemon, 1985; Krug et al., 1976; Lavi and Shatkin,
1975; Sommer et al., 1976). More recently, we and others
have shown that m6A serves as a positive regulator of HIV-1,
a retrovirus with a nuclear replication step (Kennedy et al.,
2016; Lichinchi et al., 2016; Tirumuru et al., 2016). However, a
role for m6A in regulating the life cycle of viruses that replicate
exclusively in the cytoplasm, such as viruses within the Flavivir-
idae family, has been unexplored. Flaviviridae, including Zika
virus (ZIKV), dengue virus (DENV), West Nile virus (WNV), yellow
fever virus (YFV), and hepatitis C virus (HCV), represent both
established and emerging pathogens. They contain a positive-
sense, single-stranded RNA genome that encodes a viral
polyprotein and use similar replication strategies. RNA-based
regulation of these viral genomes plays a fundamental role in
their infection, such as the liver-specific miRNA miR-122 for
HCV replication, RNA structural elements for HCV and DENV
replication, and 20-O methylation of the 50 cap of WNV RNA
for immune evasion and WNV replication (Bidet and Garcia-
Blanco, 2014; Hyde et al., 2014; Jopling et al., 2005; Mauger
et al., 2015; Pirakitikulr et al., 2016).Authors. Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
The cellular machinery that regulates m6A includes proteins
that act as writers, erasers, and readers of m6A. The addition
of m6A onmRNA, which occurs at the consensusmotif DRAmCH
(where D = G/A/U, R = G > A, and H = U/C/A), is mediated by a
methyltransferase complex containing the methyltransferase-
like (METTL) enzymes METTL3 and METTL14 and the cofactors
Wilms tumor 1-associated protein (WTAP) and KIAA1429 (Fu
et al., 2014; Liu et al., 2014; Meyer and Jaffrey, 2014; Schwartz
et al., 2014; Yue et al., 2015). The removal of m6A from mRNA
is catalyzed by the demethylases fat mass and obesity-associ-
ated protein (FTO) or a-ketoglutarate-dependent dioxygenase
AlkB homolog 5 (ALKBH5) (Jia et al., 2011; Zheng et al., 2013).
The cytoplasmic YTH-domain family 1 (YTHDF1), YTHDF2, and
YTHDF3 proteins bind to m6A through their C-terminal YTH
domain. Functionally, YTHDF1 promotes the translation of
m6A-modified mRNA, while YTHDF2 targets m6A-modified
mRNAs for degradation (Wang et al., 2014, 2015). The function
of YTHDF3 is still unknown. The discovery of these proteins
and the development of high-throughput m6A-mapping tech-
niques have led to many insights into the function of m6A (Dom-
inissini et al., 2012; Fu et al., 2014; Linder et al., 2015; Meyer
et al., 2012). Nonetheless, many aspects of the regulation of spe-
cific mRNAs by m6A remain unexplored.
Here, we define a role for m6A in regulating the life cycle
of HCV. We demonstrate that the m6A methyltransferases
negatively regulate the production of infectious HCV particles
and that the m6A-binding YTHDF proteins all relocalize to sites
of HCV particle production and suppress this stage of viral
infection. We map m6A across the HCV RNA genome and
show that preventing m6A at one of these regions enhances
viral titer by increasing the interaction of the HCV RNA with
the HCV Core protein. Finally, we describe viral RNA m6A-epi-
transcriptomic maps for several other Flaviviridae, including
ZIKV, DENV, WNV, and YFV. Altogether, our data reveal that
m6A regulates HCV infection and set the stage for the explora-
tion of the function of m6A within the broader Flaviviridae family
of viruses.
RESULTS
The m6A Machinery Regulates HCV Particle Production
To determine whether m6A regulates HCV infection, we
depleted the m6A methyltransferases METTL3 and METTL14
(METTL3+14) by small interfering RNA (siRNA) in Huh7 liver
hepatoma cells and infected these cells with HCV. Immunoblot
analysis of cell extracts harvested at 72 hr post-infection (hpi) re-
vealed that METTL3+14 depletion significantly increased the
abundance of the HCV NS5A protein, a marker of viral replica-
tion, relative to its level in cells treated with non-targeting control
siRNA (Figure 1A). Conversely, depletion of the m6A demethy-
lase FTO decreased HCV NS5A levels relative to the control
(Figure 1A). Furthermore, we found that the percentage of
HCV-positive cells increased after METTL3+14 depletion and
decreased after FTO depletion (Figures 1B, 1C, and S1A). This
change in HCV-positive cells occurred only after 24 hpi, suggest-
ing that viral entry was unaffected by m6A machinery depletion.
Depletion of them6Amachinery did not impair cell viability during
infection (Figure S1B). In addition, HCV infection slightly reduced
METTL3 protein levels in total cellular extracts, while METTL14and FTO were unaffected (Figures S1C and S1D). Thus, the
m6A methyltransferases negatively regulate HCV infection, while
the m6A demethylase positively regulates HCV infection.
We next defined the stage of the HCV life cycle regulated by
the m6A machinery. Depletion of METTL3+14 significantly
increased the production of infectious virus and viral RNA in
the supernatant compared to control siRNA at 72 hpi (Figures
1D and 1E). Conversely, depletion of FTO decreased infectious
virus and HCV RNA in the supernatant (Figures 1D and 1E)
without altering the viral-specific infectivity (Figure S1E). Deple-
tion of ALKBH5 did not affect viral titer or protein levels, indi-
cating that this demethylase does not influence the HCV life
cycle (Figure S1F). We next tested whether the altered HCV titer
after m6Amachinery depletion was due to altered viral RNA repli-
cation. In these experiments, we used Huh7.5 CD81 knockout
(KO) cells, in which essential HCV entry factor CD81 (Zhang
et al., 2004) was deleted by clustered regularly interspaced short
palindromic repeats/Cas9 (CRISPR/Cas9), resulting in cells
permissive for HCV RNA replication and viral particle production
following viral RNA transfection that are unable to support sub-
sequent rounds of viral infection (Figures S1G–S1I). In these
cells, we depleted METTL3+14 or FTO by siRNA, transfected
the cells with in vitro transcribed RNA of the HCV reporter virus
JFH1-QL/GLuc2A, and measured HCV RNA replication by as-
saying for secreted Gaussia luciferase (Yamane et al., 2014).
Depletion of METTL3+14 or FTO had no effect on Gaussia lucif-
erase levels compared to control over the time course, while our
negative control RNA containing a point mutation in the viral
RNA-dependent RNA polymerase (Pol) did not replicate (Fig-
ure 1F). These data indicate that m6A dynamics do not regulate
HCV translation or RNA replication but do regulate the produc-
tion or release of infectious viral particles.
Changes in expression of the m6A machinery have been
shown to affect cellular gene expression (Dominissini et al.,
2012; Meyer et al., 2012; Wang et al., 2014), which could indi-
rectly regulate the HCV life cycle, for example, by inducing anti-
viral interferon-stimulated genes (ISGs). While we did not find
consistent changes in ISG mRNA levels following loss of the
m6A machinery during HCV infection (48 hpi), FTO depletion
slightly increased the expression of IFITM1, which is known to
restrict HCV entry (Figure S1J) (Wilkins et al., 2013). This slight
increase occurred at both 24 and 48 hpi, although the percent-
age of HCV-positive cells following FTO depletion is the same
as control and METTL3+14 depletion at 24 hpi (Figures 1B,
S1J, and S1K). Therefore, the observed changes in infectious vi-
rus following depletion of the m6A machinery are not solely a
result of an altered antiviral response in these cells. Rather, these
data suggest that m6A acts directly on the HCV RNA genome to
regulate HCV particle production.
The m6A-Binding YTHDF Proteins Negatively Regulate
HCV Particle Production
Given that the m6A machinery regulates infectious HCV particle
production, we next tested whether the knownmediators of m6A
function, the RNA-binding YTHDF proteins, similarly regulate the
HCV life cycle. Depletion of any of the YTHDF proteins did not in-
creaseHCVNS5A protein levels at 48 hpi or HCVRNA replication
of the HCV reporter (JFH1-QL/GLuc2A) over 72 hr in Huh7.5
CD81 KO cells. However, by 72 hpi, the levels of infectiousCell Host & Microbe 20, 654–665, November 9, 2016 655
Figure 1. The m6A Machinery Regulates Infectious HCV Particle Production
(A) Immunoblot analysis of extracts of HCV-infected Huh7 cells (72 hpi) treated with siRNAs. NS5A levels were quantified relative to tubulin (n = 3). *p% 0.05 by
unpaired Student’s t test.
(B) Percentage of HCV+ cells by immunostaining of NS5A and nuclei (DAPI) after siRNA. n = 3, withR5,000 cells counted per condition. *p% 0.05, ***p% 0.001 by
two-way ANOVA with Bonferroni correction.
(C) Representative fields of HCV-infected cells (NS5A+, green) and nuclei (DAPI, blue) at 72 hpi from (B).
(D and E) FFA of supernatants harvested fromHuh7 cells 72 hpi after siRNA treatment (D). HCV RNA in supernatants harvested fromHuh7 cells 72 hpi after siRNA
treatment as quantified by qRT-PCR (E). Data are presented as the percentage of viral titer or RNA relative to control siRNA. ***p% 0.001 by unpaired Student’s
t test. Values are the mean ± SEM of three experiments in triplicate.
(F) Gaussia luciferase assay to measure HCV luciferase reporter (JFH1-QL/GLuc2A) transfected in Huh7.5 CD81 KO cells after siRNA treatment. Pol, lethal
mutation in HCV NS5B polymerase.
Values in (B) and (F) represent the mean ± SD (n = 3) and are representative of three independent experiments. See also Figure S1.HCV particles and HCV RNA in the supernatant were increased
at least 2-fold compared to control (Figures 2A–2D). Depletion
of YTHDF proteins did not affect cell viability, and HCV infection
did not alter their expression (Figures S2A and S2B). Collectively,
these data suggest that the YTHDF proteins negatively regulate
infectious HCV production without affecting overall HCV RNA
replication.
We next tested whether YTHDF proteins bind to HCV RNA by
RNA immunoprecipitation (RIP). We found that FLAG-YTHDF
ribonucleoprotein (RNP) complexes enriched HCV RNA relative
to the input, demonstrating that these proteins bind to viral
RNA (Figure 2E). Thus, YTHDF protein binding to HCV RNA
may mediate regulation of HCV particle production. This led us
to examine the subcellular localization of the YTHDF proteins
during HCV infection.656 Cell Host & Microbe 20, 654–665, November 9, 2016YTHDF Proteins Relocalize to Lipid Droplets during HCV
Infection
HCV particle assembly occurs around cytosolic lipid droplets in
close association with endoplasmic reticulum (ER) membranes.
HCV RNA and proteins, including NS5A and Core (the capsid
protein), as well as several host RNA-binding proteins that regu-
late HCV infection, accumulate around lipid droplets (Ariumi
et al., 2011; Chatel-Chaix et al., 2013;Miyanari et al., 2007; Pager
et al., 2013; Poenisch et al., 2015). Therefore, we analyzed the
subcellular localization of YTHDF proteins after HCV infection
in Huh7 cells by confocal microscopy. While YTHDF proteins
were distributed in the cytoplasm in uninfected cells, in HCV-in-
fected cells all three YTHDF proteins (both endogenous and
overexpressed) were enriched around lipid droplets (Figures 3
and S3A), in which they colocalized with the HCV Core protein.
Figure 2. The m6A-Binding YTHDF Proteins
Negatively Regulate Infectious HCV Particle
Production
(A) Immunoblot analysis of extracts of HCV-in-
fected Huh7 cells (48 hpi) treated with indicated
siRNAs.
(B and C) FFA of supernatants harvested from
Huh7 cells at 72 hpi after siRNA treatment (B). HCV
RNA in supernatants harvested from Huh7 cells
72 hpi after siRNA treatment was quantified by
qRT-PCR (C). Data were analyzed as the per-
centage of titer or HCV RNA relative to cells treated
with control siRNA. Values represent the mean ±
SEM of three (C) or four (B) experiments done in
triplicate.
(D) Gaussia luciferase assay to measure HCV
luciferase reporter (JFH1-QL/GLuc2A) transfected
in Huh7.5 CD81 KO cells after siRNA.
(E) Enrichment of HCV RNA following immuno-
precipitation of FLAG-tagged YTHDF from extracts
of Huh7 cells after 48 hpi. Left: captured HCV RNA
was quantified by qRT-PCR as the percentage of
input and graphed as fold enrichment relative to
vector. Right: immunoblot analysis of immuno-
precipitated extracts and input.
For (D) and (E), data are representative of three
experiments and show the mean ± SD (n = 3).
*p % 0.05, **p % 0.01, ***p % 0.001 by unpaired
Student’s t test. See also Figure S2.We did not observe this relocalization in Huh7 cells stably ex-
pressing a subgenomic HCV replicon that lacks the HCV struc-
tural genes and cannot produce viral particles (Figure S3B)
(Wang et al., 2003), suggesting that a fully productive HCV infec-
tion is required to trigger the relocalization of the YTHDF proteins
around lipid droplets.
HCV RNA Is Modified by m6A
We and others mapped m6A on HIV-1 mRNA and showed that it
regulates viral gene expression (Kennedy et al., 2016; Lichinchi
et al., 2016; Tirumuru et al., 2016). Although m6A has not been
found in RNAs from viruses that replicate in the cytoplasm, our
findings (Figures 1, 2, and 3) led us to hypothesize that the
HCV RNA genome is modified by m6A during infection. To test
this, we used an antibody that specifically recognizes m6A to
perform methyl-RNA immunoprecipitation (MeRIP) on total
RNA harvested from HCV-infected cells, followed by qRT-PCR
to detect enriched RNAs. HCV RNA in the eluate was specifically
enriched by the anti-m6A antibody, but not immunoglobulin G
(IgG), as was known m6A-modified mRNA SON, but not an
mRNA with little m6A modification, HPRT1 (Figure 4A) (Wang
et al., 2014). Ultra-high-pressure liquid chromatography-tandem
mass spectrometry (UPLC-MS/MS) analysis of viral RNA
captured from HCV-infected Huh7 cells using specific antisense
oligonucleotides proved that HCV RNA contains m6A, with a ra-
tio of m6A/A of approximately 0.16% (Figures S4A and S4B). TheCell Host & Manti-m6A antibody did not enrich HCV
RNA isolated from cell supernatants to
the same degree as intracellular viral
RNA (Figure 4A). We next mapped the
sites of the HCV RNA genome modifiedby m6A using MeRIP followed by sequencing (MeRIP-seq), as
previously described (Dominissini et al., 2013; Meyer et al.,
2012). We identified 19 peaks across the HCV RNA genome
common to both experimental replicates (Figures 4B and S6;
Table S1). These data present evidence that HCV, which repli-
cates exclusively in the cytoplasm, is marked by m6A during
infection.
As HCV replicates in the cytoplasm in association with intra-
cellular membranes, for its RNA to undergo m6A modification,
the m6A methyltransferases must also exist in the cytoplasm.
Our immunoblot analysis of isolated nuclear and cytoplasmic
fractions from mock or HCV-infected Huh7 cells reveals that
METTL3, METTL14, and FTO are all present in both the nucleus
and the cytoplasm, where they could interact with viral RNA
(Figures S1C and S1D). This is in concordance with reports
that have detected both METTL3 and m6A-methyltransferase
activity in cytoplasmic extracts (Chen et al., 2015; Harper
et al., 1990; Lin et al., 2016). Therefore, these data reveal that
the m6A machinery are in the cytoplasm, where they can modify
cytoplasmic HCV RNA.
Because the cellular function of m6A is carried out by the
YTHDF proteins, which are bound to HCV RNA (Figure 2E),
we hypothesized that one or more of the YTHDF proteins would
bind to functionally relevant m6A sites on the HCV RNA genome.
We directly mapped these YTHDF-binding sites on the
viral genome using photoactivatable ribonucleoside-enhancedicrobe 20, 654–665, November 9, 2016 657
Figure 3. YTHDF Proteins Relocalize to Lipid Droplets during HCV Infection
(A) Confocal micrographs of HCV-infected or uninfected Huh7 cells (48 hpi) immunostained with antibodies to YTHDF (green) and HCV Core (red) proteins. Lipid
droplets (gray) and nuclei (blue) were labeled with BODIPY and DAPI, respectively. Zoom panels are derived from the white box in the merge panels. Scale
bar, 10 mm.
(B) Enrichment of YTHDF proteins around lipid droplets was quantified using ImageJ from more than ten cells analyzed and graphed in box-and-whisker plots,
representing the minimum, first quartile, median, third quartile, and maximum. **p% 0.01, ***p% 0.001 by unpaired Student’s t test.
See also Figure S3.crosslinking and immunoprecipitation (PAR-CLIP) in HCV-in-
fected Huh7 single-cell clones stably expressing these proteins
or GFP (Figure S4C) (Hafner et al., 2010; Kennedy et al., 2016).
We identified 42 different sites on the HCV RNA genome that
were bound by at least one YTHDF protein, not by GFP, and con-
tained the characteristic T-to-C transition that derives from
reverse transcription of cross-linked 4SU residues (Table S2).
Surprisingly, only two high-confidence YTHDF-binding sites
(bound by more than one YTHDF protein) overlapped with the
m6A peaks identified by all replicates of MeRIP-seq, and only
55% of the YTHDF-binding sites contained the DRAmCH motif
required for m6A (Table S2). Altogether, these data build a map
of m6A- and YTHDF-binding sites on the HCV RNA genome.658 Cell Host & Microbe 20, 654–665, November 9, 2016m6A-Abrogating Mutations in the HCV E1 Genomic
Region Increase Viral Particle Production
To elucidate the functional relevance of a specificm6A site on the
HCV genome, we made mutations in the genome to inactivate
this modification. We identified only one region of the HCV
genome, within the viral E1 gene, that both contains m6A and
is bound by YTHDF proteins at sites with consensus DRAmCH
motifs (Tables S1 and S2). This region of the genome has been
shown to lack major RNA secondary structure (Pirakitikulr
et al., 2016) and contains a cluster of four potential m6A sites
(Figure 5A). Comparative sequence analysis of the nucleotides
in these sites revealed that the first m6A site is identical in 72
strains of genotype 2A, while the m6A motif in the latter three
Figure 4. HCV RNA Is Modified by m6A
(A) MeRIP-qRT-PCR analysis of intracellular or supernatant RNA harvested from HCV-infected Huh7.5 cells (72 hpi) and immunoprecipitated with anti-m6A or
IgG. Eluted RNA is quantified as a percentage of input. Values are the mean ± SD (n = 3). **p% 0.01, ***p% 0.001 by unpaired Student’s t test.
(B) Map of m6A-binding sites in the HCVRNA genome byMeRIP-seq (representative of two independent samples) of RNA isolated fromHCV-infected Huh7 cells.
Read coverage, normalized to the total number of reads mapping to the viral genome for each experiment, is in red for MeRIP-seq and in blue for input RNA-seq.
Red bars indicate m6A peaks identified in duplicate experiments by MeRIPPeR analysis (FDR-corrected q value < 0.05). See also Figures S4 and S6 and Tables
S1 and S2.sites is conserved among 26 representative strains of HCV from
different genotypes (Figure S5A).We thenmutated either the A or
the C within the consensus site to a U in the four identified m6A
sites in the E1 gene to construct HCV-E1mut. These mutations
abrogate the potential for m6A modification (Kane and Beemon,
1987) without altering the encoded amino acid sequence
(Figure 5A).
To determine the role of these m6A sites in the HCV life cycle,
we electroporated wild-type (WT) and E1mut HCV RNA into
Huh7 cells and measured the production of infectious virus at
48 hpi. E1mut produced nearly 3-fold more viral titer in superna-
tant than WT, while the Pol RNA did not produce titer (Fig-
ure 5B). E1mut also increased both intracellular and extracellular
titer, suggesting that these mutations increased viral particle
assembly (Figure S5B). To determine whether abrogation of
the E1 m6A sites affected HCV RNA replication, we then
measured replication of the WT or E1mut JFH1-QL/GLuc2A re-
porter after transfection into Huh7.5 CD81 KO cells. The E1 mu-
tations did not alter HCV RNA replication over a time course
(Figure 5C) or the levels of viral Core protein (Figure 5D). Alto-
gether, these data suggest that m6A within the E1 gene nega-
tively regulates infectious HCV particle production, similar to
our findings with depletion of the m6A methyltransferases and
YTHDF proteins.
While the YTHDF proteins bind to multiple sites on HCV RNA,
comparison ofMeRIP-seqwith the PAR-CLIP data suggests that
their binding to the HCV RNA genome is not always m6A depen-
dent (Figure 4B; Table S2). Therefore, to test whether the m6A-
abrogating mutations in E1 affect binding by YTHDF proteins
within this region, we measured FLAG-YTHDF2 binding to a re-
porter RNA containing 100 nucleotides of WT or E1mut, allowing
us to isolate the interaction of a single m6A region with a single
YTHDF protein. Mutation of the m6A sites within the E1 region
reduced binding of FLAG-YTHDF2 by 50% compared to theWT by YTHDF2 RIP, while FLAG-YTHDF2 bound equally to
known m6A-modified mRNA SON in both conditions (Figure 5E).
Furthermore, depletion of YTHDF1 did not increase extracellular
HCV RNA produced by cells infected with E1mut HCV over cells
treated with control siRNA (Figure S5C).
The HCV Core protein binds to the HCV RNA genome during
assembly of viral particles. Core protein is known to bind to
HCV RNA around the E1 region that contains our identified
m6A sites (Shimoike et al., 1999). To test whether m6A in E1 influ-
ences Core binding to viral RNA, we immunoprecipitated Core
RNP complexes from cells electroporated with WT or E1mut
HCV RNA. We found that mutation of the m6A sites within the
E1 region increases HCV RNA binding to the Core protein by
nearly 2-fold compared to WT (Figure 5F). Altogether, these
data suggest that YTHDF proteins bind to the m6A sites within
the HCV E1 region to mediate the negative regulation of infec-
tious HCV particle production, while the Core protein binds to
viral RNA genomes lacking m6A within the E1 region for pack-
aging into nascent viral particles.
Mapping of m6A within the Viral RNA Genomes of the
Flaviviridae Family of Viruses
Because we found that the HCV RNA genome contains m6A, we
wanted to investigate the location of m6A on the RNA genomes
of other members of the Flaviviridae family. We performed
MeRIP-seq in duplicate on RNA isolated from Huh7 cells in-
fected with DENV (DENV2-NGC), YFV (17D), WNV (TX), and
ZIKV (PR2015 or DAK). Our data identified reproducible m6A
sites within all five viral genomes (Figures 6A–6E and S6; Table
S3). Some m6A sites on these viral genomes occurred within
similar genetic regions among all Flaviviridae (Figure 6F). In
particular, the NS3 and NS5 genes contained m6A peaks, remi-
niscent of the pattern on the HCV RNA genome and suggesting
a conserved role for these sites in regulating these viral lifeCell Host & Microbe 20, 654–665, November 9, 2016 659
Figure 5. m6A-Abrogating Mutations in E1
Increase Infectious HCV Particle Production
(A) Schematic of the HCV genome with the muta-
tion scheme for altering A or C residues (red ar-
rows) to make the E1mut virus. Consensus m6A
motifs (green) and inactivating mutations (red) are
shown. Dashes represent nucleotides not shown.
Genomic indices match the HCV JFH-1 genome
(AB047639).
(B) FFA of supernatants harvested from Huh7 cells
after electroporation of WT or E1mut HCV RNA
(48 hr) and analyzed as the percentage of viral titer
relative to WT.
(C) Gaussia luciferase assay to measure levels of
the WT, E1mut, or Pol HCV luciferase reporter
(JFH1-QL/GLuc2A) transfected in Huh7.5 CD81
KO cells.
(D) Immunoblot analysis of extracts of WT, E1mut,
or Pol JFH1-QL/GLuc2A transfected in Huh7.5
CD81 KO cells.
(E) Enrichment ofWT or E1mut reporter RNA orSON
mRNA by immunoprecipitation of FLAG-YTHDF2
or vector from extracts of Huh7 cells. Captured
RNA was quantified by qRT-PCR and graphed as
the percentage of input. Right: immunoblot anal-
ysis of anti-FLAG immunoprecipitated extracts
and input.
(F) Enrichment of WT or E1mut HCV RNA by
immunoprecipitation of HCV Core from extracts of
Huh7 cells electroporated with the indicated viral
genomes (48 hr). Lower: immunoblot analysis of
anti-Core immunoprecipitated extracts and input.
Data are representative of two (D and E) or three
(B, C, and F) experiments and presented as
the mean ± SD (n = 3). *p % 0.05, **p % 0.01,
***p% 0.001 by unpaired Student’s t test. See also
Figure S5.cycles. Furthermore, similar to HCV, DENV and ZIKV (PR2015)
contained an m6A peak in the envelope gene. Therefore, these
data suggest a potentially conserved set of m6A-epitranscrip-
tome sites in the Flaviviridae family that could regulate viral
RNA function, virulence, and transmission.
DISCUSSION
The function of m6A in regulating host and viral infection is only
now emerging, even though nuclear-replicating viruses have
been known to contain m6A since the 1970s (Dimock and Stoltz-
fus, 1977; Kane and Beemon, 1985; Krug et al., 1976; Lavi and
Shatkin, 1975; Sommer et al., 1976). Recent studies have estab-
lished a pro-viral role for m6A during HIV-1 infection (Kennedy
et al., 2016; Lichinchi et al., 2016; Tirumuru et al., 2016). In our
study, in which we define function for m6A and its cellular ma-
chinery in regulating the positive-strand RNA genome of the
cytoplasmic virus HCV, we find that m6A negatively regulates
HCV particle production. Furthermore, we find that the posi-
tive-strand RNA genomes of other viruses within the Flaviviridae
family, including two strains of ZIKV, are modified by m6A in
conserved genomic regions. Altogether, this work reveals that660 Cell Host & Microbe 20, 654–665, November 9, 2016Flaviviridae RNA genomes harbor RNA regulatory marks that
could affect their life cycles and virulence.
The known enzymes and RNA-binding proteins that regulate
m6A also regulate the life cycle of HCV. Depletion of the m6A
methyltransferases METTL3 and METTL14 increases the rate
of HCV infection by promoting infectious viral particle production
without affecting viral RNA replication. Depletion of the m6A de-
methylase FTO, but not ALKBH5, has the opposite effect (Fig-
ure 1). These effects do not appear to be caused by dysregulated
induction of host ISGs after depletion of the m6A machinery,
because changes in ISG expression were minimal (Figure S1).
Instead, we hypothesize that the m6A machinery directly modu-
lates the levels of m6A on the HCV genome to regulate its func-
tion, and this is supported by our finding that HCV RNA contains
m6A. While it is known that m6A functions on host mRNAs to
regulate their stability, translation, localization, and interactions
with RNA-binding proteins (Fu et al., 2014), we hypothesize
that the function of m6A in HCV RNA is not due to regulation of
HCV RNA stability or translation, because our studies of HCV
RNA replication using a reporter virus found no change in re-
porter levels following depletion of the m6A machinery. Rather,
our data suggest that m6A regulates infectious viral particle
Figure 6. Mapping m6A in the RNA Genomes of Flaviviridae
(A–E) Read coverage of Flaviviridae genomes of (A) DENV, (B) YFV, (C) ZIKV (DAK), (D) ZIKV (PR2015), and (E) WNV for one replicate of MeRIP-seq (red), and input
RNA-seq (blue) from matched samples. Colored bars indicate m6A peaks identified by MeRIPPeR analysis. (n = 2; FDR-corrected q value < 0.05).
(F) Alignment of replicate m6A sites in the genomes of DENV (red), YFV (blue), ZIKV (DAK) (orange), ZIKV (PR2015) (green), and WNV (brown).
See also Figure S6 and Table S3.production through interactions of the viral RNA with host and
viral proteins.
Because the writers (METTL3+14) and an eraser (FTO) of m6A
regulated HCV particle production, it was reasonable to hypoth-
esize that the m6A-binding YTHDF reader proteins would have a
similar effect. All three YTHDF proteins bound to HCV RNA at
similar sites and their depletion increased HCV particle produc-
tion, suggesting that their effect on HCV particle production was
due to binding HCV RNA (Figure 2; Table S2). Although YTHDF1
and YTHDF2 have been found to have divergent functions on
host mRNAs, all three YTHDF proteins in our study acted simi-
larly to suppress HCV (Wang et al., 2014, 2015). Likewise, duringHIV-1 infection, all three YTHDF proteins function similarly to one
another, although they have been described to have both pro-
and anti-HIV function (Kennedy et al., 2016; Tirumuru et al.,
2016). During HCV infection, YTHDF regulatory function is likely
related to their relocalization to lipid droplets, the sites of viral as-
sembly (Figure 3). Many RNA-binding proteins relocalize to lipid
droplets in HCV-infected cells and regulate HCV particle produc-
tion (Ariumi et al., 2011; Chatel-Chaix et al., 2013; Pager et al.,
2013; Poenisch et al., 2015). Many of these proteins are known
to interact with YTHDF proteins, suggesting that these interac-
tions could regulate HCV particle production (Schwartz et al.,
2014; Wang et al., 2015). Consequently, it will be important inCell Host & Microbe 20, 654–665, November 9, 2016 661
the future to identify any YTHDF protein-protein interactions en-
riched during HCV infection, which may point to a regulatory
network of RNA-binding proteins that affect infectious HCV par-
ticle production.
We found that about 50% of YTHDF protein-binding sites
identified on HCV RNA using PAR-CLIP overlapped with
MeRIP-seq m6A peaks (Figure 4). These results are similar to
previous studies examining the overlap of YTHDF1 or YTHDF2
PAR-CLIP with MeRIP-seq data, which have found about a
60% overlap (Wang et al., 2014, 2015). We hypothesize that
the non-overlapping YTHDF-binding sites in HCV RNA represent
m6A sites not detected byMeRIP-seq due to biological variation,
technical noise, or potentially sites that might be bound by
YTHDF proteins in an m6A-independent fashion. A report found
that YTHDF proteins bound to an in vitro transcribed, and
hence non-methylated, HCV RNA genome (Rı´os-Marco et al.,
2016). Therefore, future studies could reveal functions of the
YTHDF proteins that are independent of m6A during the HCV
life cycle.
To discern the function of an m6A site on HCV RNA during
infection, we abrogated m6A modification in the E1 region of
HCV by mutation. This E1mut virus produced higher viral titers
than the WT virus (Figure 5), similar to what we found with
METTL3+14 and YTHDF depletion and suggesting a conserved
regulatory mechanism between both m6A and the YTHDF pro-
teins at this site. The presence of these mutations in E1
increased HCV RNA binding to Core protein while reducing
binding to YTHDF2. This suggests that interactions of the HCV
RNA with Core are regulated by m6A such that viral genomes
lacking m6A in the E1 region are preferentially segregated for
packaging into nascent virions. Therefore, we hypothesize that
the presence or absence of m6A in E1 facilitates competition be-
tween YTHDF protein and HCVCore binding to the viral genome,
leading to the cellular retention or packaging of HCV RNA,
respectively.
Because RNA viruses can rapidly evolve under selection pres-
sure, the maintenance of m6A sites on the HCV genome sug-
gests that m6A must confer an evolutionary advantage to the
virus. In HCV, whose pathology is characterized by chronic pro-
gression during infection in the liver, a slower replication rate has
been linked to persistent infection through an evasion of immune
surveillance (Bocharov et al., 2004). Therefore, m6A may boost
viral fitness by allowing HCV to establish slow, persistent infec-
tions. Pirakitikulr et al. (2016) identified a conserved stem loop
in the E1 coding region, just downstream of our identified m6A
sites, that suppresses viral particle production without affecting
viral RNA replication. This raises the possibility that within the E1
region, multiple RNA elements, including m6A, play a role in
segregating the RNA genome between stages of the HCV life
cycle.
The function of the other m6A sites on the HCV RNA genome
remains unknown. Because many of these sites do not overlap
with YTHDF protein-binding sites, they may directly modify
HCV RNA structure or recruit alternative m6A readers, such as
HNRNPA1/B2, eIF3, or even METTL3 (Alarco´n et al., 2015; Lin
et al., 2016; Meyer et al., 2015). They may also contribute to anti-
viral innate immune evasion, because the presence of m6A on
RNA has been shown to reduce its activation of toll-like receptor
3 signaling (Kariko´ et al., 2005). While we did not identify m6A in662 Cell Host & Microbe 20, 654–665, November 9, 2016the known poly-U/UC pathogen-associated molecular patterns
in the 30 UTR of the HCV genome, we did find that YTHDF2 binds
close to this region (Table S2), so future studies can begin to
discern whether m6A plays a role in HCV innate immune evasion.
We found that four other Flaviviridae (DENV, YFV, ZIKV, and
WNV) also contained m6A within their viral genomes. Because
these viruses replicate in the cytoplasm, our data reveal that
m6A methyltransferases are functional in the cytoplasm. Similar
to the results of others, we detected the m6A machinery in cyto-
plasmic fractions (Figure S1C) (Chen et al., 2015; Harper et al.,
1990; Lin et al., 2016). Therefore, cellular mRNAs could also be
dynamically regulated by m6A modification following export
into the cytoplasm. These viruses had prominent m6A peaks in
NS5, which encodes their viral RNA-dependent RNA polymer-
ase, strongly suggesting the presence of a conserved RNA reg-
ulatory element here. Both DENV and ZIKV (PR2015) contained
m6A peaks within their envelope genes, similar to HCV, and
future studies to determine whether these m6A sites also affect
production of infectious flaviviral particles will be of interest.
While the genomic RNA structures for DENV, YFV, ZIKV, and
WNV have not yet been determined, these viral genomes contain
specific RNA regulatory structures, especially within their UTRs.
We found that two of the mosquito-transmitted viruses, DENV
and YFV, have m6A within their 30 UTRs (Figure 6F). In DENV,
the 30 UTR has two stem loops that regulate mosquito to human
transmission (Villordo et al., 2015). Therefore, it is possible that
m6A patterns and functionality in the mosquito-transmitted flavi-
viral genomes could contribute to vector-borne transmission.
Finally, we observed clear differences in m6A patterns between
the Dakar and the Puerto Rican isolates of ZIKV, which represent
the African and the Asian lineages, respectively (Haddow et al.,
2012). Because these lineages have differences in human dis-
ease, with increased pathogenicity ascribed to the Asian lineage
of ZIKV (Weaver et al., 2016), the differences in regulation of
these viruses by m6A could contribute to these varied infection
outcomes.
In summary, we present global m6A profiling of RNA viruses
within the Flaviviridae family. In addition, we provide evidence
that an exclusively cytoplasmic RNA ismodified bym6A. Further-
more, we present a role of this modification in regulating HCV
RNA function at the level of infectious viral particle production.
This work sets the stage to broadly study the role of m6A in Fla-
viviridae infection, transmission, and pathogenesis. This work
also has the potential to uncover regulatory strategies to inhibit
replication by these established and emerging viral pathogens.EXPERIMENTAL PROCEDURES
Cell Lines
Human hepatoma Huh7, Huh7.5, and Huh7.5 CD81 KO cells were grown in
DMEM (Mediatech) supplemented with 10% fetal bovine serum (HyClone),
2 5 mM HEPES, and 13 non-essential amino acids (complete [c]DMEM;
Thermo Fisher Scientific). HCV-K2040 (1B) replicon cells (Wang et al., 2003)
were cultured in cDMEM containing 0.2 mg/mL geneticin (Thermo Fisher Sci-
entific). The identity of the Huh7 and Huh7.5 cell lines was verified using the
Promega GenePrint STR kit (DNA Analysis Facility, Duke University), and cells
were verified asmycoplasma free by the LookOut Mycoplasma PCR detection
kit (Sigma). Huh7.5 CD81 KO cells were generated by CRISPR, as described
before, with details given in the Supplemental Experimental Procedures (Hop-
craft et al., 2016; Hopcraft and Evans, 2015).
Viral Infections and Generation of Viral Stocks
HCV
Infectious stocks of a cell culture-adapted strain of genotype 2A JFH1 HCV
were generated and titrated by focus-forming assay (FFA), as described
(Aligeti et al., 2015). HCV infections were performed at an MOI of 0.3 for
72 hr unless noted.
WNV
Working stocks ofWNV isolate TX 2002-HC (WNV-TX) were generated in BHK-
21 cells and titered as described (Suthar et al., 2010). WNV infections (MOI 5)
were performed in Huh7 cells for 48 hr.
DENV and YFV
Preparation and titering of DENV2-NGC and YFV-17D stocks has been
described (Le Sommer et al., 2012; Sessions et al., 2009). DENV and YFV in-
fections (MOI 2) were performed for 24 hr in Huh7 cells.
ZIKV
ZIKV_PR2015 (PRVABC59) stocks were prepared and titered as described
(Quicke et al., 2016). ZIKV_DAK (Zika virus/A.africanus-tc/SEN/1984/41525-
DAK) stocks were generated and titered by FFA in Vero cells (Le Sommer
et al., 2012). ZIKV infections (MOI 2) were performed in Huh7 cells for 24 hr.
FFA for HCV Titer
Supernatants were collected and filtered through 0.45 mMsyringe filters. Serial
dilutions of supernatants were used to infect naive Huh7.5 cells in triplicate
wells of a 48-well plate. At either 48 or 72 hpi, cells were fixed, permeabilized,
and immunostained with HCV NS5A antibody (1:500; gift of Charles Rice,
Rockefeller University). Following binding of horseradish peroxidase (HRP)-
conjugated secondary antibody (1:500; Jackson ImmunoResearch), infected
foci were visualized with the VIP Peroxidase Substrate Kit (Vector Labora-
tories) and counted at 403 magnification. Titer (in focus-forming units per
milliliter) was calculated as described (Gastaminza et al., 2006). To measure
intracellular HCV titer, cells pellets were washed in PBS, resuspended in
serum-free media, and subjected to five rounds of freezing and thawing in a
dry ice and ethanol bath. Lysate was cleared by centrifugation, and FFA was
performed as described earlier.
MeRIP-Seq
Poly(A)+ RNA purified from at least 75 mg total RNA (Poly(A) Purist Mag kit;
Thermo Fisher Scientific) extracted from HCV-, DENV-, YFV-, WNV-, ZIKV
(DAK)-, and ZIKV (PR2015)-infected samples was fragmented using the Am-
bion RNA fragmentation reagent and purified by ethanol precipitation. Frag-
mented RNA was heated to 75C for 5 min, placed on ice for 3 min, and
then incubated with anti-m6A antibody (5 mg; Synaptic Systems, #202111)
conjugated to Protein G Dynabeads (50 mL; Thermo Fisher Scientific) in MeRIP
buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA, and 0.1% NP-40)
overnight at 4C. Beads were then washed 53 with MeRIP buffer, and bound
RNA was eluted in MeRIP buffer containing 6.7 mM m6A sodium salt (Sigma).
Eluted RNA was purified with the Quick-RNA miniprep kit (Zymo Research)
and concentrated by ethanol precipitation. Sequencing libraries were pre-
pared from this RNA, as well as input RNA, using the TruSeq RNA sequencing
(RNA-seq) kit (Illumina). Libraries were sequenced to 1 3 50 base-pair reads
on the Illumina HiSeq2500 at theWeill Cornell Medicine Epigenomics Core Fa-
cility. Reads were aligned to combined human (hg19) and viral genomes using
Spliced Transcripts Alignment to a Reference (STAR), with a mapping quality
threshold of 20. Despite the poly(A) enrichment, a significant number of reads
mapped to the viral genomes. We identified peaks using MeRIPPeR (https://
sourceforge.net/projects/meripper/), which defines peaks in m6A immunopre-
cipitation (IP) over input control read counts using Fisher’s exact test, with a
minimum peak size of 100 bases. The false discovery rate (FDR) was set
to <0.05 using a Benjamini-Hochberg correction. Intersections between the
peaks called by two replicates provided the final set of peak calls. MeRIP-
qRT-PCR followed this protocol, except that total RNA was not fragmented.
Eluted RNA was reverse transcribed into cDNA and subjected to qRT-PCR.
Statistical Analysis
Student’s unpaired t test and two-way ANOVA (with Bonferroni correction)
were used for statistical analysis of the data using GraphPad Prism software.
Graphed values are presented as mean ± SD (n = 3 or as indicated); *p% 0.05,
**p% 0.01, and ***p% 0.001.Additional experimental procedures can be found in the Supplemental
Experimental Procedures.
ACCESSION NUMBERS
The accession number for the raw sequencing data obtained from the MeRIP-
seq and PAR-CLIP and reported in this paper is GEO: GSE83438.
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